<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report a case of spontaneous left pulmonary artery <z:mp ids='MP_0005048'>thrombosis</z:mp> in a 3-day-old male neonate </plain></SENT>
<SENT sid="1" pm="."><plain>The presentation of <z:chebi fb="5" ids="28304">heparin</z:chebi> resistance and <z:mp ids='MP_0005048'>thrombosis</z:mp> raised the possibility of a type II <z:chebi fb="5" ids="28304">heparin</z:chebi> binding site <z:e sem="disease" ids="C0272375" disease_type="Disease or Syndrome" abbrv="">antithrombin deficiency</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>A continuous infusion of antithrombin concentrate was used successfully, following failure of plasma, to correct the <z:chebi fb="5" ids="28304">heparin</z:chebi> resistance </plain></SENT>
<SENT sid="3" pm="."><plain>Rapid genetic analysis allowed sequencing of the antithrombin gene within 5 working days </plain></SENT>
<SENT sid="4" pm="."><plain>This showed the infant to be homozygous for the substitution of C to T at nucleotide 2759 </plain></SENT>
<SENT sid="5" pm="."><plain>This base change causes mutation of the native leucine at codon 99 to a phenylalanine </plain></SENT>
<SENT sid="6" pm="."><plain>This antithrombin variant has been previously reported (antithrombin Budapest 3) and results in reduced binding of <z:chebi fb="5" ids="28304">heparin</z:chebi> to antithrombin </plain></SENT>
<SENT sid="7" pm="."><plain>Such a molecular diagnostic approach is feasible and warranted in such cases of neonatal <z:mp ids='MP_0005048'>thrombosis</z:mp> because of the diagnostic difficulties encountered </plain></SENT>
</text></document>